Compound Detail
CHEMBL63175
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCN)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O
Basic Information
| ChEMBL ID | CHEMBL63175 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CTVDXWAMOJGHNA-ZOMYCCNSSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
602.7
MW (Da)
1.70
ALogP
10
HBA
5
HBD
192.3
PSA (Ų)
0.16
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.1
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SK-BR-3 | IC50 | = | 80.0 | nM | 7.1 | Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... | 7562911 |
| A2780 | IC50 | = | 136.0 | nM | 6.87 | Compound was evaluated for antiproliferative activity against human ovarian carc... | 11514145 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7562911 | 10.1021/jm00019a010 | SK-BR-3 | 1 |
| 11514145 | 10.1016/s0960-894x(01)00374-2 | A2780 | 1 |
Data from ChEMBL 36 via Core Engine